DIM
MIST icon

DC Investments Management’s Milestone Pharmaceuticals MIST Stock Holding History

DC Investments Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-39,038
Closed -$1.06M – 329
2019
Q2 		$1.06M Buy
+39,038
New +$805K 0.59% 7

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

DC Investments Management's MIST Position: Q3 2019 in Review

DC Investments Management sold out of Milestone Pharmaceuticals (MIST) in Q3 2019, closing a stake of 39,038 shares — an estimated $1.06M sold.

DC Investments Management first reported a position in MIST in Q2 2019 and held it in 1 quarter. The position peaked at $1.06M in Q2 2019. 23 funds tracked by Wall St. Rank hold MIST as of Q3 2019.

  • DC Investments Management reported no remaining Milestone Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • DC Investments Management sold 39,038 Milestone Pharmaceuticals shares in Q3 2019, an estimated $1.06M.
  • DC Investments Management first reported a position in Milestone Pharmaceuticals in Q2 2019 and held it in 1 quarter.
  • DC Investments Management's Milestone Pharmaceuticals position peaked at $1.06M in Q2 2019.
  • 23 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2019.

Based on DC Investments Management's 13F filing for Q3 2019, filed 5 Nov 2019.